Priya Choudhry
YOU?
Author Swipe
View article: Efficacy, Hemodynamic Stability and Safety of Hyperbaric Bupivacaine versus Hyperbaric Ropivacaine in Spinal Anaesthesia for Elective Caesarean Sections: A Randomised Controlled Trial
Efficacy, Hemodynamic Stability and Safety of Hyperbaric Bupivacaine versus Hyperbaric Ropivacaine in Spinal Anaesthesia for Elective Caesarean Sections: A Randomised Controlled Trial Open
View article: Functional multiomics reveals genetic and pharmacologic regulation of surface CD38 in multiple myeloma
Functional multiomics reveals genetic and pharmacologic regulation of surface CD38 in multiple myeloma Open
View article: Functional glycoproteomics by integrated network assembly and partitioning
Functional glycoproteomics by integrated network assembly and partitioning Open
SUMMARY The post-translational modification (PTM) of proteins by O-linked β- N -acetyl-D-glucosamine (O-GlcNAcylation) is widespread across the proteome during the lifespan of all multicellular organisms. However, nearly all functional stu…
View article: The surfaceome of multiple myeloma cells suggests potential immunotherapeutic strategies and protein markers of drug resistance
The surfaceome of multiple myeloma cells suggests potential immunotherapeutic strategies and protein markers of drug resistance Open
View article: Functional multi-omics reveals genetic and pharmacologic regulation of surface CD38 in multiple myeloma
Functional multi-omics reveals genetic and pharmacologic regulation of surface CD38 in multiple myeloma Open
CD38 is a surface ectoenzyme expressed at high levels on myeloma plasma cells and is the target for the monoclonal antibodies (mAbs) daratumumab and isatuximab. Pre-treatment CD38 density on tumor cells is an important determinant of mAb e…
View article: Defining the cell surface proteomic landscape of multiple myeloma reveals immunotherapeutic strategies and biomarkers of drug resistance
Defining the cell surface proteomic landscape of multiple myeloma reveals immunotherapeutic strategies and biomarkers of drug resistance Open
The myeloma cell surface proteome (“surfaceome”) not only determines tumor interaction with the microenvironment but serves as an emerging arena for therapeutic development. Here, we use glycoprotein capture proteomics to first define surf…
View article: CRISPR-based screens uncover determinants of immunotherapy response in multiple myeloma
CRISPR-based screens uncover determinants of immunotherapy response in multiple myeloma Open
Cancer cells commonly develop resistance to immunotherapy by loss of antigen expression. Combinatorial treatments that increase levels of the target antigen on the surface of cancer cells have the potential to restore efficacy to immunothe…
View article: Proteasome inhibitor-induced modulation reveals the spliceosome as a specific therapeutic vulnerability in multiple myeloma
Proteasome inhibitor-induced modulation reveals the spliceosome as a specific therapeutic vulnerability in multiple myeloma Open
Enhancing the efficacy of proteasome inhibitors (PI) is a central goal in myeloma therapy. We proposed that signaling-level responses after PI may reveal new mechanisms of action that can be therapeutically exploited. Unbiased phosphoprote…
View article: DNA methyltransferase inhibitors upregulate CD38 protein expression and enhance daratumumab efficacy in multiple myeloma
DNA methyltransferase inhibitors upregulate CD38 protein expression and enhance daratumumab efficacy in multiple myeloma Open
Author(s): Choudhry, Priya; Mariano, Margarette C; Geng, Huimin; Martin, Thomas G; Wolf, Jeffrey L; Wong, Sandy W; Shah, Nina; Wiita, Arun P
View article: Efficient tumor killing and minimal cytokine release with novel T-cell agonist bispecific antibodies
Efficient tumor killing and minimal cytokine release with novel T-cell agonist bispecific antibodies Open
T-cell-recruiting bispecific antibodies (T-BsAbs) have shown potent tumor killing activity in humans, but cytokine release-related toxicities have affected their clinical utility. The use of novel anti-CD3 binding domains with more favorab…
View article: Proteasome inhibitor-induced modulation reveals the spliceosome as a specific therapeutic vulnerability in multiple myeloma
Proteasome inhibitor-induced modulation reveals the spliceosome as a specific therapeutic vulnerability in multiple myeloma Open
Enhancing the efficacy of proteasome inhibitors is a central goal in myeloma therapy. We proposed that signaling-level responses after PI would reveal new mechanisms of action that could be therapeutically exploited. Unbiased phosphoproteo…
View article: Seeking Convergence and Cure with New Myeloma Therapies
Seeking Convergence and Cure with New Myeloma Therapies Open
View article: High-Throughput Method for Automated Colony and Cell Counting by Digital Image Analysis Based on Edge Detection
High-Throughput Method for Automated Colony and Cell Counting by Digital Image Analysis Based on Edge Detection Open
Counting cells and colonies is an integral part of high-throughput screens and quantitative cellular assays. Due to its subjective and time-intensive nature, manual counting has hindered the adoption of cellular assays such as tumor sphero…